Israel Englander Lantheus Holdings, Inc. Call Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$77.7 - $123.62 $14.2 Million - $22.7 Million	-183,300 Reduced 96.88%	5,900 $647,000
Q2 2024 Aug 14, 2024	BUY	$58.87 - $83.05 $10.1 Million - $14.2 Million	171,300 Added 956.98%	189,200 $15.2 Million
Q1 2024 May 15, 2024	SELL	$51.07 - $68.26 $1.27 Million - $1.69 Million	-24,800 Reduced 58.08%	17,900 $1.11 Million
Q4 2023 Feb 14, 2024	SELL	$55.6 - $77.89 $405,880 - $568,597	-7,300 Reduced 14.6%	42,700 $2.65 Million
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $4.12 Million - $4.98 Million	50,000 New	50,000 $4.2 Million

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.41B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.